» Articles » PMID: 21455099

Protective Effect of Bilberry (Vaccinium Myrtillus) Against Doxorubicin-induced Oxidative Cardiotoxicity in Rats

Overview
Journal Med Sci Monit
Date 2011 Apr 2
PMID 21455099
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Doxorubicin (DOX) is a commonly used chemotherapeutic agent. It is associated with serious dose-limiting cardiotoxicity, which is at least partly caused by generation of reactive oxygen species (ROS). Supplementations with bilberries were effective in reducing oxidative stress in many tissue injuries due their high content of antioxidants. The present study investigated the potential protective effect of bilberry extract against DOX-induced cardiotoxicity in rats.

Material/methods: Rats were treated orally with a methanolic extract of bilberry for 10 days. DOX was injected intraperitoneally on day 7. Twenty-four hours after the last bilberry administration, rats were subjected to ECG study. Blood was then withdrawn and cardiac tissues were dissected for assessment of oxidative stress and cardiac tissue injury. Cardiac tissues were also subjected to histopathological examination.

Results: Bilberry extract significantly inhibited DOX-provoked reduced glutathione depletion and accumulation of oxidized glutathione, malondialdehyde and protein carbonyls in cardiac tissues. This was accompanied by significant amelioration of reduced cardiac catalase, superoxide dismutase, and glutathione peroxidase activities; and increased cardiac myeloperoxidase activity in response to DOX challenge. Pretreatment with bilberry significantly guarded against DOX-induced increase in serum activities of lactate dehydrogenase, creatine phosphokinase and creatine kinase-MB, as well as the level of troponin I. Bilberry alleviated ECG changes in rats treated with DOX and attenuated its pathological changes.

Conclusions: Bilberry protects against DOX-induced cardiotoxicity in rats. This can be attributed, at least in part, to its antioxidant activity.

Citing Articles

Potential ameliorative effects of bilberry (Vaccinium myrtillus L.) fruit extract on cisplatin-induced reproductive damage in adult male albino rats.

Mossa F, Bakry N, El-Sawi M Clin Exp Reprod Med. 2024; 51(3):192-204.

PMID: 39210717 PMC: 11372312. DOI: 10.5653/cerm.2023.06380.


Antiaging, Brightening, and Antioxidant Efficacy of Fermented Bilberry Extract (): A Randomized, Double-Blind, Placebo-Controlled Trial.

Nobile V, Dudonne S, Kern C, Roveda G, Garcia C Nutrients. 2024; 16(14).

PMID: 39064646 PMC: 11280171. DOI: 10.3390/nu16142203.


and -Two Species-One Used as a Functional Food.

Kopystecka A, Koziol I, Radomska D, Bielawski K, Bielawska A, Wujec M Nutrients. 2023; 15(19).

PMID: 37836403 PMC: 10574057. DOI: 10.3390/nu15194119.


Anti-Inflammatory Activity of Bilberry ( L.).

Sharma A, Lee H Curr Issues Mol Biol. 2022; 44(10):4570-4583.

PMID: 36286028 PMC: 9601269. DOI: 10.3390/cimb44100313.


Tea Grape Reduces Abdominal Aortic Occlusion-Induced Lung Injury.

Hemsinli D, Ergene S, Karakisi S, Mercantepe T, Tumkaya L, Yilmaz A Braz J Cardiovasc Surg. 2020; 35(4):512-520.

PMID: 32864932 PMC: 7454615. DOI: 10.21470/1678-9741-2019-0392.


References
1.
Elberry A, Abdel-Naim A, Abdel-Sattar E, Nagy A, Mosli H, Mohamadin A . Cranberry (Vaccinium macrocarpon) protects against doxorubicin-induced cardiotoxicity in rats. Food Chem Toxicol. 2010; 48(5):1178-84. DOI: 10.1016/j.fct.2010.02.008. View

2.
Morishima I, Matsui H, Mukawa H, Hayashi K, Toki Y, Okumura K . Melatonin, a pineal hormone with antioxidant property, protects against adriamycin cardiomyopathy in rats. Life Sci. 1998; 63(7):511-21. DOI: 10.1016/s0024-3205(98)00302-6. View

3.
Heinonen M . Antioxidant activity and antimicrobial effect of berry phenolics--a Finnish perspective. Mol Nutr Food Res. 2007; 51(6):684-91. DOI: 10.1002/mnfr.200700006. View

4.
Nazeyrollas P, Prevost A, Baccard N, Manot L, Devillier P, Millart H . Effects of amifostine on perfused isolated rat heart and on acute doxorubicin-induced cardiotoxicity. Cancer Chemother Pharmacol. 1999; 43(3):227-32. DOI: 10.1007/s002800050888. View

5.
Ibrahim M, Ashour O, Ibrahim Y, El-Bitar H, Gomaa W, Abdel-Rahim S . Angiotensin-converting enzyme inhibition and angiotensin AT(1)-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity. Pharmacol Res. 2009; 60(5):373-81. DOI: 10.1016/j.phrs.2009.05.007. View